Application no. and date | 14846953.9 (espacenet) (Federated) (European Patent Register), 20140925 | Patent/reg. no. and date | DK/EP 3049473, 20210922 | Publication date | 20160803 | Priority no. and date | US 201361882500 P, 20130925 | EP pub. no. and date |
EP 3049473 20160803 | Effective date | | Applicant/owner | Engene, Inc., 7171 Frederick-Banting
Montreal, Quebec H4S 1Z9, CA | Applicant ref. no. | V2111-092-DK | Inventor | HSU, Eric, 5870 Fremlin Street
Vancouver, British Columbia V5Z 3W7, CA, GAO, Jun, 607 Langside Avenue
Coquitlam, British Columbia V3J 2Y7, CA, CHEUNG, Anthony, 2301-8 Smithe Mews
Vancouver, British Columbia V6B 0A5, CA | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | Opponent | | IPC Class | A61K 47/36 (2006.01) , A61K 48/00 (2006.01) , A61K 9/14 (2006.01) , A61K 9/51 (2006.01) , C07H 21/00 (2006.01) , C08B 37/08 (2006.01) , C08L 5/08 (2006.01) , C12N 15/87 (2006.01) , C12N 15/88 (2006.01) | Title | DOBBELTDERIVATISEREDE CHITOSANNANOPARTIKLER OG FREMGANGSMÅDER TIL FREMSTILLING OG ANVENDELSE HERAF TIL GENOVERFØRSEL IN VIVO | Int. application no. | CA2014050921 | Int. publication no. | WO2015042711 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|